Legend Biotech Corp (LEGN)
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. Legend Biotech Corporation was founded in 2014 and is headquartered in Somerset, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Legend Biotech Corporation
NASDAQ:LEGNHealthcare · Biotechnology
-3.00%$21.63
AH$21.74+0.51%vs close
Mkt Cap$4.21B
Float162.91M
O/S194.49M
Vol
$ Vol
RVOL
Inst Own52.0%
SI8.5%
Earnings
Dilution
Financials Summary
Revenue$1.03B
Net Income-$296.8M
Total Assets$1.73B
Free Cash Flow-$168.04M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$413.7M
Total Equity$1B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in LEGN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.73B
Liabilities$731.6M
Accounts Receivable$250.3M
Accounts Payable$81.2M
Inventory$32M
PP&E (Net)$402M
Goodwill$0
Intangible Assets$74.6M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $1.03B | $627.24M | $285.14M | $117M | $68.83M | $75M | $61.8M | $49.13M | $23.59M |
| YoY Growth | 64.0% | 120.0% | 143.7% | 70.0% | -8.2% | 21.4% | 25.8% | 108.2% | - |
| Cost of Revenue | $408.1M | $234.58M | $144.21M | $65.36M | $0 | $0 | $0 | $0 | -$96K |
| Gross Profit | $620.8M | $392.66M | $140.93M | $51.64M | $68.83M | $75M | $61.8M | $49.13M | $23.69M |
| Gross Margin | 60.3% | 62.6% | 49.4% | 44.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.4% |
| Research and Development | $414.7M | $413.54M | $382.22M | $335.65M | $313.35M | $232.16M | $161.94M | $60.64M | $8.2M |
| Selling, General, and Administrative | $341.6M | $284.26M | $200.93M | $174.05M | $149.5M | $72.7M | $32.37M | $3.93M | $1.4M |
| Other | $1M | -$1.91M | -$2.73M | -$2.43M | -$1.74M | -$229.87M | $0 | -$2K | $0 |
| Total Operating Expenses | $757.3M | $695.9M | $580.41M | $507.26M | $461.11M | $75M | $194.31M | $64.2M | $9.6M |
| Operating Income (EBIT) | -$136.5M | -$303.24M | -$439.49M | -$455.62M | -$392.29M | $0 | -$132.51M | -$1.53M | $13.78M |
| Operating Margin | -13.3% | -48.3% | -154.1% | -389.4% | -570.0% | - | -214.4% | -3.1% | 58.4% |
| Interest Expense | $21.4M | $21.61M | $21.79M | $10.8M | $900K | $4.21M | $223K | $82K | $0 |
| Interest Income | $40.1M | $61.2M | $54.49M | $8.18M | $971K | $2.93M | $4.58M | $6.21M | $1K |
| Other Income (Expense) | -$146.1M | $145.11M | -$80.63M | $9.9M | -$14.91M | -$308.29M | $5.2M | $13.46M | -$40K |
| Income Before Tax (EBT) | -$282.6M | -$158.13M | -$520.12M | -$445.72M | -$407.2M | -$308.29M | -$127.32M | -$1.62M | $13.84M |
| Income Tax Expense | $14.2M | $18.89M | -$1.86M | $625K | -$3.61M | -$41.91M | -$25.73M | $1.17M | $4.47M |
| Net Income | -$296.8M | -$177.03M | -$518.25M | -$446.35M | -$403.58M | -$266.37M | -$101.59M | -$2.78M | $9.37M |
| Net Income Margin | -28.8% | -28.2% | -181.8% | -381.5% | -586.4% | -355.2% | -164.4% | -5.7% | 39.7% |
| Supplementary Data | |||||||||
| EPS | -1.60 | -0.97 | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 | 0.07 |
| Diluted EPS | -1.60 | -0.97 | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 | 0.07 |
| Weighted Average OS | 184.32M | 182.85M | 176.08M | 159.04M | 140.85M | 118.15M | 132.01M | 100.00M | 132.01M |
| EBITDA | -$232.3M | -$113.16M | -$477.87M | -$416.54M | -$392.38M | -$298.16M | -$127.25M | $149K | $14.06M |
| EBITDA Margin | -22.6% | -18.0% | -167.6% | -356.0% | -570.1% | -397.5% | -205.9% | 0.3% | 59.6% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $901.9M | $286.75M | $1.28B | $786.03M | $688.94M | $456.07M | $83.62M | $210.17M | $2.12M |
| Short-Term Investments | $46.7M | $835.93M | $31M | $239.62M | $193.46M | $50M | $75.56M | $6.01M | $0 |
| Cash and Short-Term Investments | $948.6M | $1.12B | $1.31B | $1.03B | $882.39M | $506.07M | $159.18M | $216.18M | $2.12M |
| Accounts Receivable | $250.3M | $124.89M | $157.06M | $44.52M | $58.55M | $82.62M | $35.76M | $108.57M | $228.74M |
| Inventory | $32M | $23.9M | $19.43M | $10.35M | $1.75M | $1.8M | $1.16M | $1.14M | $11K |
| Other Current Assets | $1.6M | $70K | $357K | $1.27M | $1.44M | $0 | $0 | $255K | $760K |
| Total Current Assets | $1.25B | $1.28B | $1.5B | $1.1B | $949.85M | $593.94M | $207.1M | $326.96M | $230.9M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $402M | $201.59M | $189.68M | $161.67M | $142.96M | $112.11M | $80.09M | $33.13M | $2.93M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $74.6M | $174.22M | $4.06M | $68.69M | $16.8M | $2.85M | $519K | $49K | $2K |
| Long-Term Investments | $5M | $4.36M | $4.36M | $0 | $4.71M | $0 | $0 | -$1.24M | -$4.86M |
| Deferred Tax Assets | $0 | $0 | $285K | $0 | $0 | $0 | $0 | $68.92M | $4.86M |
| Other Long-Term Assets | $5M | $6.06M | $152.42M | $1.49M | $5.15M | $13.19M | $0 | $1.24M | $4.86M |
| Total Long-Term Assets | $486.6M | $386.24M | $350.81M | $231.84M | $169.62M | $128.15M | $80.61M | $102.09M | $7.79M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $722.09M | $287.71M | $429.05M | $238.69M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $81.2M | $37.19M | $20.16M | $31.69M | $7.04M | $4.91M | $9.59M | $7.32M | $4.33M |
| Short-Term Debt | $319.1M | $0 | $0 | $0 | $0 | $1.79M | $1.03M | $0 | $0 |
| Current Income Tax Payable | $0 | $24.04M | $7.2M | $10.79M | $10M | $8.79M | $0 | $74.54M | $9.33M |
| Current Unearned Revenue | $11.3M | $47.41M | $53.01M | $451K | $304K | $55.01M | $46.29M | $40.32M | $30.21M |
| Other Current Liabilities | $1M | $500K | $68K | $67M | $87.9M | $31.45M | $64.22M | $34.16M | $38.08M |
| Total Current Liabilities | $636.4M | $277.64M | $216.42M | $297.79M | $229.2M | $115.57M | $127.76M | $159.19M | $52.12M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $301.2M | $281.33M | $260.93M | $120.46M | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $6.15M | $55.27M | $7.66M | $1.87M | $275.07M | $277.74M | $257.27M | $174.2M |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $4.24M | $0 | -$213.2M | -$174.2M |
| Other Long-Term Liabilities | $8M | -$54K | $56K | $233K | $396K | -$274.52M | $0 | $0 | $0 |
| Total Long-Term Liabilities | $95.2M | $351.96M | $380.82M | $288.86M | $124.32M | $6.7M | $282.82M | $261.21M | $174.4M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $731.6M | $629.61M | $597.24M | $586.65M | $353.52M | $122.27M | $410.58M | $420.4M | $226.53M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $100K | $37K | $36K | $33K | $31K | $27K | $20K | $20K | $20K |
| Retained Earnings | -$1.96B | -$1.66B | -$1.48B | -$966.46M | -$520.11M | -$116.53M | -$127.28M | $5.69M | $8.47M |
| Comprehensive Income & Other | $122.2M | -$68.16M | $98.92M | $14.67M | $4.86M | $5.96M | $485K | $8.63M | -$236K |
| Other Stockholders' Equity | $2.96B | $2.7B | $2.74B | $1.71B | $1.29B | $714.27M | $4.39M | $2.94M | $3.67M |
| Total Equity | $1B | $1.04B | $1.25B | $744.31M | $765.94M | $597.77M | -$122.87M | $8.65M | $12.17M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $720.04M | $287.71M | $429.05M | $238.69M |
| Supplementary Data | |||||||||
| Total Debt | $413.7M | $350.6M | $328.67M | $284.53M | $122.97M | $3.7M | $6.11M | $4.32M | $269K |
| Net Debt | -$488.2M | $63.85M | -$949.04M | -$501.5M | -$565.97M | -$452.37M | -$77.51M | -$205.85M | -$1.85M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$297.58M | -$158.13M | -$520.12M | -$445.72M | -$407.2M | -$308.29M | -$130.37M | -$1.62M | $9.37M |
| Depreciation & Amortization | $28.9M | $23.36M | $20.45M | $18.39M | $13.92M | $9.93M | $5.26M | $1.68M | $217K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | -$7.35M | -$5.66M | $0 |
| Stock-Based Compensation | $0 | $68.94M | $47.68M | $34.34M | $20.16M | $4.76M | $1.27M | $704K | $0 |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | -$132.85M | $93.75M | -$98.98M | $50.32M | $24.59M | -$45M | -$3.77M | $207.61M | -$228.06M |
| Inventory | -$4.51M | -$17.21M | -$12.71M | -$13.89M | $51K | -$643K | -$22K | -$1.12M | -$6K |
| Accounts Payable | $44.52M | $14.06M | -$50.2M | $72.45M | $1.8M | -$4.35M | $2.01M | $3.24M | $4.17M |
| Other Working Capital | -$501K | -$70.57M | $90.54M | $72.16M | $135.39M | $26.75M | $54.27M | $108.99M | $207.4M |
| Total Working Capital Change | -$93.35M | $20.04M | -$71.34M | $181.03M | $161.83M | -$23.24M | $52.48M | $318.71M | -$16.5M |
| Other Non-Cash Items | $261.57M | -$98.24M | $130.06M | $10.68M | $12.82M | $93.83M | -$4.36M | -$6.13M | $228.87M |
| Net Cash from Operating | -$100.47M | -$144.03M | -$393.28M | -$201.28M | -$198.47M | -$223M | -$83.06M | $307.68M | -$2.38M |
| Investing Activities | |||||||||
| Capital Expenditures | -$67.58M | -$14.11M | -$20.08M | -$20.93M | -$42.2M | -$26.25M | -$39.17M | -$21.02M | -$887K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | -$460K | $20K | $60K |
| Purchases of Investments | -$4.55B | -$2.71B | -$4.86B | -$654.97M | -$377.96M | -$72.68M | -$390.4M | -$6M | $0 |
| Sales of Investments | $5.33B | $1.93B | $5.08B | $614.86M | $230.08M | $98.29M | $320.85M | $0 | $0 |
| Other Investing Activities | $0 | -$54.34M | -$100.52M | -$16.05M | -$4.91M | -$23.52M | $50.52M | -$75.23M | $55K |
| Net Cash from Investing | $711.48M | -$850.54M | $92.79M | -$77.09M | -$194.98M | -$24.17M | -$58.65M | -$102.26M | -$827K |
| Financing Activities | |||||||||
| Debt Repaid | - | $4.02M | $3.75M | $2.6M | $1.42M | $2.6M | $5.06M | $219K | $32K |
| Common Stock Issuance | $3.31M | $0 | $0 | $377.64M | $623.44M | $462.08M | $0 | $0 | $1.43M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$3.61M | $9.72M | $795.25M | $2.93M | $4.64M | -$1.05M | $19.72M | $2.72M | $3.35M |
| Net Cash from Financing | -$301K | $5.7M | $791.49M | $377.98M | $626.66M | $618.88M | $14.67M | $2.5M | $3.32M |
| Forex Effect | $4.37M | -$2.08M | $682K | -$2.51M | $34K | $620K | $249K | $124K | $9K |
| Net Change in Cash | $615.09M | -$990.96M | $491.68M | $97.09M | $233.25M | $372.32M | -$126.8M | $208.05M | $128K |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$100.47M | -$144.03M | -$393.28M | -$201.28M | -$198.47M | -$223M | -$83.06M | $307.68M | -$2.38M |
| Capital Expenditure | -$67.58M | -$14.11M | -$22.72M | -$22.27M | -$45.4M | -$30.28M | -$39.17M | -$21.02M | -$887K |
| Free Cash Flow | -$168.04M | -$158.14M | -$416M | -$223.56M | -$243.87M | -$253.29M | -$122.23M | $286.66M | -$3.26M |
| Cash at Beginning | $286.82M | $1.28B | $786.03M | $688.94M | $455.69M | $83.36M | $210.17M | $2.12M | $1.99M |
| Cash at End | $901.9M | $286.75M | $1.28B | $786.03M | $688.94M | $455.69M | $83.36M | $210.17M | $2.12M |